| 000 | 01742 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518014835.0 | ||
| 264 | 0 | _c20200730 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a2146-8427 | ||
| 024 | 7 |
_a10.6002/ect.2018.0043 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHage, Valérie | |
| 245 | 0 | 0 |
_aIncidence of Donor-Specific Anti-HLA Antibodies in Non-HLA-Sensitized Patients Given Tacrolimus Once or Twice Daily During the First 2 Years After Kidney Transplant. _h[electronic resource] |
| 260 |
_bExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _c06 2019 |
||
| 300 |
_a313-319 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies _xblood |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHLA Antigens _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Donors |
| 700 | 1 | _aFerrandiz, Inès | |
| 700 | 1 | _aBéllière, Julie | |
| 700 | 1 | _aEsposito, Laure | |
| 700 | 1 | _aHebral, Anne Laure | |
| 700 | 1 | _aCointault, Olivier | |
| 700 | 1 | _aDel Bello, Arnaud | |
| 700 | 1 | _aKamar, Nassim | |
| 773 | 0 |
_tExperimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation _gvol. 17 _gno. 3 _gp. 313-319 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.6002/ect.2018.0043 _zAvailable from publisher's website |
| 999 |
_c29214092 _d29214092 |
||